| __timestamp | Bio-Techne Corporation | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 21263000 |
| Thursday, January 1, 2015 | 40853000 | 18890000 |
| Friday, January 1, 2016 | 45187000 | 15295000 |
| Sunday, January 1, 2017 | 53514000 | 12944000 |
| Monday, January 1, 2018 | 55329000 | 13599000 |
| Tuesday, January 1, 2019 | 62413000 | 30391000 |
| Wednesday, January 1, 2020 | 65192000 | 13020000 |
| Friday, January 1, 2021 | 70603000 | 16287000 |
| Saturday, January 1, 2022 | 87140000 | 19943000 |
| Sunday, January 1, 2023 | 92493000 | 21042000 |
| Monday, January 1, 2024 | 96664000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Bio-Techne Corporation has consistently outpaced Vericel Corporation in R&D investments. From 2014 to 2023, Bio-Techne's R&D expenses surged by approximately 212%, peaking in 2023. In contrast, Vericel's R&D spending showed a more modest increase of around 1% over the same period, with a notable spike in 2019.
Bio-Techne's commitment to innovation is evident, with its R&D spending reaching nearly three times that of Vericel by 2023. This trend underscores Bio-Techne's strategic focus on expanding its product pipeline and maintaining a competitive edge. Meanwhile, Vericel's fluctuating R&D investments suggest a more cautious approach, potentially reflecting different strategic priorities or market conditions. As we look to the future, these spending patterns may offer insights into each company's growth trajectory and market positioning.
Comparing Innovation Spending: Novartis AG and Bio-Techne Corporation
R&D Insights: How Bio-Techne Corporation and Lantheus Holdings, Inc. Allocate Funds
Bio-Techne Corporation or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Research and Development Investment: Bio-Techne Corporation vs CRISPR Therapeutics AG
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Perrigo Company plc
Analyzing R&D Budgets: Bio-Techne Corporation vs MorphoSys AG
Research and Development: Comparing Key Metrics for Madrigal Pharmaceuticals, Inc. and Vericel Corporation
Who Prioritizes Innovation? R&D Spending Compared for Bausch Health Companies Inc. and Vericel Corporation
Who Prioritizes Innovation? R&D Spending Compared for Vericel Corporation and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Vericel Corporation and Travere Therapeutics, Inc.
Research and Development Investment: Vericel Corporation vs Taro Pharmaceutical Industries Ltd.
Vericel Corporation or Viridian Therapeutics, Inc.: Who Invests More in Innovation?